SKNRX | SKSRX | SKNRX / SKSRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 20 years | - |
Gain YTD | 4.693 | 4.635 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | 500 | 1000 | 50% |
Net Assets | 928M | 928M | 100% |
Annual Yield % from dividends | 1.79 | 1.98 | 90% |
Returns for 1 year | 8.52 | 8.82 | 97% |
Returns for 3 years | 4.48 | 5.08 | 88% |
Returns for 5 years | 40.01 | 41.23 | 97% |
Returns for 10 years | 17.50 | 19.78 | 88% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SFEPX | 20.43 | 0.19 | +0.94% |
NAA Large Core P | |||
PCBAX | 14.75 | 0.03 | +0.20% |
BlackRock Tactical Opportunities Inv A | |||
PQSCX | 24.99 | 0.02 | +0.08% |
Virtus KAR Small-Cap Value C | |||
ECASX | 28.97 | -0.02 | -0.07% |
Eaton Vance Atlanta Capital SMID-Cap C | |||
LYFCX | 12.39 | -0.10 | -0.80% |
AlphaCentric Life Sciences & Hlthcare C |